Clinical Trials in Seattle

Showing 1841-1860 of 4,491 trials

Clinical Trial Proximal Caries Infiltration and Detection

NCT01796106

The purpose of this study is to investigate the clinical efficacy of resin infiltration (Icon, DMG, Germany) compared to fluoride varnish (Duraphat Fluoride Varnish, Colgate, USA) in the management of proximal early caries lesions in primary molars over 24 months. In addition, this study will assess the use of a scanning fiber endoscope (SFE) laser optical device for the assessment of caries lesions and their progression in comparison to radiographic examination. A total of 50 participants (age 6-13 years) with at least 1 proximal early caries lesion will be enrolled. The participants will be followed up at 12 and 24 months. Lesion status will be monitored through radiographic and SFE laser optical device imaging.

Caries,Dental

DMG Dental Material Gesellschaft mbH12 participantsStarted Mar 2015

Seattle, Washington, United States

COMPLETEDPhase 3< 1 mile

Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)

NCT01844518

The purpose of this study is to estimate Abatacept steady-state trough concentration (Cmin) at Day 113 in children and adolescents with pJIA

Active Polyarticular Juvenile Idiopathic Arthritis

Bristol-Myers Squibb219 participantsStarted Aug 2013

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Hartford, Connecticut, United States +54 more locations

Clinical Trial Proximal Caries Infiltration and Detection

Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)

Find Trials by Condition in Seattle

Open-Label Dose-Ranging Study of Oral SM-001 in Healthy Adults

Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer

Blood Pressure Lowering in Dialysis (BOLD) Trial

PNT2258 for Treatment of Patients With Richter's Transformation (Brighton)

Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years

Web-based vs In-person Personalized Feedback Intervention for Comorbid Substance Use and Disordered Gambling

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis

Simple Bone Cysts in Kids

Canadian-American Spinal Cord Perfusion Pressure and Biomarker Study

A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)

A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804

Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE

The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR)

Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)

A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma